https://www.marketscreener.com/quote/stock/VERRICA-PHARMACEUTICALS-I-44247380/news/Verrica-Pharmaceuticals-Announces-Extension-of-FDA-Review-Period-of-its-NDA-for-VP-102-for-the-Treat-33513584/?utm_source=telegram&utm_medium=social&utm_campaign=share